Verification of EZH2 as a Druggable Target in Metastatic Uveal Melanoma
Molecular Cancer - United Kingdom
doi 10.1186/s12943-020-01173-x
Full Text
Open PDFAbstract
Available in full text
Date
March 4, 2020
Authors
Publisher
Springer Science and Business Media LLC